Abstract
Epilepsy is a common condition in the population of people with intellectual disability and for many proves intractable. Over the last 20 years a host of new antiseizure medications (antiepileptics) have been introduced to the market, and the evidence base to support their use in people with intellectual disability is reviewed. This will aim to cover new treatment approaches such as cannabinoid preparations succinctly.
| Original language | English |
|---|---|
| Title of host publication | The Frith Prescribing Guidelines for People with Intellectual Disability |
| Publisher | Cambridge University Press |
| Chapter | 17 |
| Publication status | Published - 7 Nov 2024 |